Key Takeaways New clinical trials and innovative product launches are expected to drive market adoption, improve margins, and accelerate growth in large, underpenetrated therapy areas. Expanding globally with an enhanced sales force and continued investment in data and technology supports sustainable earnings, better pricing, and long-term competitive strength.